NASDAQ: ALZN - Alzamend Neuro, Inc.

Lønnsomhet i seks måneder: -69.7%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan Alzamend Neuro, Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet Alzamend Neuro, Inc.

Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders.

flere detaljer
The company's pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002 stage, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2021-06-15
ISIN US02262M3088
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.alzamend.com
Цена ао 0.9952
Prisendring per dag: -3.23% (1.24)
Prisendring per uke: +8.11% (1.11)
Prisendring per måned: -5.14% (1.265)
Prisendring over 3 måneder: -32.2% (1.77)
Prisendring over seks måneder: -69.7% (3.96)
Prisendring per år: +34.83% (0.89)
Prisendring over 3 år: -42.86% (2.1)
Prisendring over 5 år: 0% (1.2)
Prisendring over 10 år: 0% (1.2)
Prisendring siden begynnelsen av året: -8.4% (1.31)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 0 0
P/BV -1.85 0
P/E 0 0
EV/EBITDA -0.4789 0
Total: 2.5

Effektivitet

Navn Betydning Karakter
ROA, % -303.88 0
ROE, % -4408.31 0
Total: 1.67

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.0304 10
Total: 8.6

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 0 0
Lønnsomhet Ebitda, % 124.7 10
Lønnsomhet EPS, % 29906.76 10
Total: 8
Flere detaljer

Institusjoner Volum Dele, %
Truist Financial Corp 154327 2.25
Vanguard Group Inc 78545 1.14
Geode Capital Management, LLC 52397 0.76
Blackrock Inc. 39740 0.58
HRT Financial LP 16806 0.24
RFG Advisory, LLC 16666 0.24
Renaissance Technologies, LLC 10190 0.15
Tower Research Capital LLC (TRC) 3316 0.05
UBS Group AG 1909 0.03
HARBOR INVESTMENT ADVISORY, LLC 200 0



Veileder Stillingstittel Betaling Fødselsår
Mr. Stephan Jackman CEO & Director 434.24k 1976 (49 år)
Mr. David J. Katzoff Chief Financial Officer 116.67k 1962 (63 år)
Mr. Henry C. W. Nisser Esq. Executive VP, General Counsel & Director 50k 1969 (56 år)
Mr. Milton Charles Ault III Founder & Vice Chairman N/A 1970 (55 år)

Adresse: United States, Atlanta. GA, 3480 Peachtree Road NE - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.alzamend.com